Cochrane "evidence relevant to" rehabilitation of people with post COVID-19 condition. What it is and how it has been mapped to inform the development of the World Health Organization recommendations.


Journal

European journal of physical and rehabilitation medicine
ISSN: 1973-9095
Titre abrégé: Eur J Phys Rehabil Med
Pays: Italy
ID NLM: 101465662

Informations de publication

Date de publication:
Dec 2022
Historique:
pubmed: 6 12 2022
medline: 1 2 2023
entrez: 5 12 2022
Statut: ppublish

Résumé

Cochrane Rehabilitation developed a series of actions to provide the global rehabilitation community with the best available evidence to respond to the COVID-19 pandemic. These initiatives constituted the REH-COVER (Rehabilitation COVID-19 evidence-based response) action. In March 2020, the first initiative started in agreement with the European Journal of Physical and Rehabilitation Medicine (EJPRM): the rapid systematic review of all papers relevant to COVID-19 rehabilitation to inform rehabilitation health professionals rapidly. Currently, we are facing the long-term consequences of COVID-19, initially called "long Covid" and now named post COVID-19 condition (PCC), which led to the request by the WHO Rehabilitation Programme for evidence synthesis to support the development of specific recommendations. Cochrane Rehabilitation provided the best available evidence from the REH-COVER rapid living systematic review results, a systematic scoping review on the models of care and a summary of "evidence relevant to" the rehabilitation for adults with PCC. Based on this evidence, expert groups developed the 16 recommendations for the rehabilitation of adults with PCC recently published in Chapter 24 of the WHO "Clinical management of COVID-19 living guideline." This paper aims to introduce the Special Section of EJPRM reporting the work performed by Cochrane Rehabilitation to produce a summary of the existing "evidence relevant to" the rehabilitation of adults with PCC. The paper reports the methodology (overview of systematic reviews with mapping) and introduces the concept of "evidence relevant to" rehabilitation.

Identifiants

pubmed: 36468825
pii: S1973-9087.22.07793-0
doi: 10.23736/S1973-9087.22.07793-0
pmc: PMC10077960
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

853-856

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Références

Eur J Phys Rehabil Med. 2021 Apr;57(2):181-188
pubmed: 33599442
Arch Phys Med Rehabil. 2019 Aug;100(8):1492-1498
pubmed: 30831091
BMJ. 2017 Sep 21;358:j4008
pubmed: 28935701
Bull World Health Organ. 2022 Nov 1;100(11):676-688
pubmed: 36324552
Eur J Phys Rehabil Med. 2020 Jun;56(3):354-360
pubmed: 32408729
Eur J Phys Rehabil Med. 2020 Aug;56(4):508-514
pubmed: 32539312
Eur J Phys Rehabil Med. 2020 Oct;56(5):672-681
pubmed: 32990687
Eur J Phys Rehabil Med. 2018 Apr;54(2):125-155
pubmed: 29565101
Eur J Phys Rehabil Med. 2020 Jun;56(3):347-353
pubmed: 32316718
Eur J Phys Rehabil Med. 2021 Oct;57(5):850-857
pubmed: 34749491
Arch Phys Med Rehabil. 2021 Jul;102(7):1424-1430
pubmed: 33716115
Eur J Phys Rehabil Med. 2020 Oct;56(5):652-657
pubmed: 32869962
Eur J Phys Rehabil Med. 2022 Jun;58(3):333-341
pubmed: 35306803
J Clin Epidemiol. 2021 Oct;138:194-198
pubmed: 34089780
Eur J Phys Rehabil Med. 2020 Oct;56(5):642-651
pubmed: 32705860
Eur J Phys Rehabil Med. 2020 Oct;56(5):667-671
pubmed: 32935959
Eur J Phys Rehabil Med. 2021 Jun;57(3):478-480
pubmed: 34002977

Auteurs

Stefano Negrini (S)

Department of Biomedical, Surgical and Dental Sciences, University "La Statale", Milan, Italy.
IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.

Carlotte Kiekens (C)

IRCCS MultiMedica, Milan, Italy.

Claudio Cordani (C)

IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.

Chiara Arienti (C)

IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy - carienti@dongnocchi.it.

Wouter DE Groote (W)

Rehabilitation Programme, Non-communicable Diseases Department, WHO, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH